AstraZeneca Pharma India Ltd 506820
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 5,341.25
- Day Range
- INR 5,126.00–5,374.95
- 52-Week Range
- INR 3,131.10–7,208.00
- Bid/Ask
- INR 5,356.00 / INR 5,356.10
- Market Cap
- INR 134.30 Bil
- Volume/Avg
- 3,853 / 1,392
Key Statistics
- Price/Earnings (Normalized)
- 70.83
- Price/Sales
- 11.16
- Dividend Yield (Trailing)
- 0.30%
- Dividend Yield (Forward)
- 0.30%
- Total Yield
- 0.30%
Company Profile
AstraZeneca Pharma India Ltd is engaged in the manufacture, distribution, and marketing of pharmaceutical products. Its only operating segment being Healthcare. The company generates revenue from the sale of products such as Tablets, Injectables, and Inhalation. Geographically, it derives a majority of revenue from India. It focuses on areas such as Cardiovascular, Renal and Metabolism (CVRM), Oncology, Respiratory, Inflammation and Autoimmunity, Neuroscience and Infection and Vaccines.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 947
- Website
- https://www.astrazeneca.com
Comparables
Valuation
|
Metric
|
506820
|
543322
|
500674
|
|---|---|---|---|
Price/Earnings (Normalized) | 70.83 | 21.59 | 32.34 |
Price/Book Value | 20.39 | 4.36 | 20.25 |
Price/Sales | 11.16 | 4.46 | 6.80 |
Price/Cash Flow | 91.60 | 18.63 | 33.18 |
Price/Earnings
506820
543322
500674
Financial Strength
|
Metric
|
506820
|
543322
|
500674
|
|---|---|---|---|
Quick Ratio | 1.52 | 2.64 | 0.84 |
Current Ratio | 2.19 | 4.37 | 1.92 |
Interest Coverage | 123.37 | 409.34 | 498.35 |
Quick Ratio
506820
543322
500674
Profitability
|
Metric
|
506820
|
543322
|
500674
|
|---|---|---|---|
Return on Assets (Normalized) | — | 16.82% | 33.84% |
Return on Equity (Normalized) | — | 20.87% | 61.98% |
Return on Invested Capital (Normalized) | — | 20.73% | 54.92% |
Return on Assets
506820
543322
500674
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Bmvlxcpvj | Zmz | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Cdxvhvdzj | Gvtzn | $69.1 Bil | |
HLN
| Haleon PLC ADR | Jvvqtvlnd | Dqhv | $37.8 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Nzykkdcqv | Ygkd | $15.7 Bil | |
VTRS
| Viatris Inc | Cczjrmqf | Mdvbg | $13.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Mqcyyzzc | Xjr | $12.4 Bil | |
CTLT
| Catalent Inc | Svffqspt | Wqzgkd | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Szqccrcd | Cys | $4.5 Bil | |
CURLF
| Curaleaf Holdings Inc | Sptfjfwf | Ppcx | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Nkhggdg | Hfmhnl | $3.5 Bil |